Back | Next |
home / stock / aimd / aimd message board
Subject | By | Source | When |
---|---|---|---|
This thing is going to fly. $AMAR | GreenKnight | investorshub | 09/14/2020 3:47:12 PM |
Amarillo Biosciences to Initiate Low-Dose Interferon Clinical Trials | adijas | investorshub | 09/10/2020 5:27:11 PM |
$AMAR - I like this - https://www.globenewswire.com/news-release/2020/09/10/2092 | GreenKnight | investorshub | 09/10/2020 5:27:07 PM |
Another Form 4. | Quintessence | investorshub | 01/10/2019 11:08:25 PM |
Several form 4s out recently. Hoping PPS | Quintessence | investorshub | 01/07/2019 10:50:36 PM |
Guillotine goes chop. | willlbone | investorshub | 11/29/2018 7:43:29 PM |
Press Release | InforichIH | investorshub | 12/29/2016 3:09:02 PM |
AMARQ: Emerged from Bankruptcy. 1-19 R/S pursuant to | Renee | investorshub | 12/16/2014 9:39:39 PM |
Thanks drug man for great info. | Mm26 | investorshub | 06/05/2014 2:21:11 PM |
Form 8-K for AMARILLO BIOSCIENCES INC | drugmanrx | investorshub | 06/01/2014 9:03:52 PM |
Anyone know what happend to chapter 11 filings?is | Mm26 | investorshub | 06/01/2014 8:51:32 PM |
Saw this on Gold Medal Stocks. So nice | Sage7243 | investorshub | 02/16/2014 3:50:00 PM |
that's all | fast.money | investorshub | 02/12/2014 2:08:43 PM |
I sent two different emails in two email | kura | investorshub | 02/12/2014 1:48:22 AM |
$AMARQ $ NOW # 11 and | knrorrel | investorshub | 02/11/2014 6:25:58 AM |
$AMARQ TODAY UP TO 0,05 + $$$$$$ | knrorrel | investorshub | 02/11/2014 5:52:30 AM |
Does $AMARQ have any pending pdufa dates or | Zer0Veritas | investorshub | 02/11/2014 5:28:41 AM |
is there still something left in the tank | OTCdoc | investorshub | 02/11/2014 1:13:30 AM |
Things are looking up for this company with | jedijazz | investorshub | 02/10/2014 8:57:03 PM |
$$$ >FABULOUS DAY here for AMARlQ!!!! & | logical cash | investorshub | 02/10/2014 7:59:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Ainos Inc Company Name:
AIMD Stock Symbol:
OTCMKTS Market:
Study to evaluate clinical effectiveness of low-dose oral interferons in treating chronic gingivostomatitis in cats, building upon VELDONA's history in animal health since 1985 Clinical trials are expected to run for approximately ten months from May 24, 2024. SAN DIEGO, CA / ACCESSWIRE...
Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024 US$9M growth capital secured in May strengthens financial position for executing growth strategy SAN DIEGO, CA / ACCESSWIRE / May 13, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...